Studies of peripheral arterial disease (PAD) in minority populations provide researchers with an opportunity to evaluate PAD risk factors and disease severity under different types of conditions. Examination 1 of the Strong Heart Study (1989)(1990)(1991)(1992) provided data on the prevalence of PAD and its risk factors in a sample of American Indians. Participants (/V = 4,549) represented 13 tribes located in three geographically diverse centers in the Dakotas, Oklahoma, and Arizona. Participants in this epidemiologic study were aged 45-74 years; 60% were women. Using the single criterion of an ankle brachial index less than 0.9 to define PAD, the prevalence of PAD was approximately 5.3% across centers, with women having slightly higher rates than men. Factors significantly associated with PAD in univariate analyses for both men and women included age, systolic blood pressure, hemoglobin A1c level, albuminuria, fibrinogen level, fasting glucose level, prevalence of diabetes mellitus, and duration of diabetes. Multiple logistic regression analyses were used to predict PAD for women and men combined. Age, systolic blood pressure, current cigarette smoking, pack-years of smoking, albuminuria (microand macro-), low density lipoprotein cholesterol level, and fibrinogen level were significantly positively associated with PAD. Current alcohol consumption was significantly negatively associated with PAD. In American Indians, the association of albuminuria with PAD may equal or exceed the association of cigarette smoking with PAD. Am J Epidemiol 1999; 149:330-8.
Comparisons of prevalences and incidence rates of peripheral arterial disease (PAD) between populations and among racial/ethnic subgroups offer epidemiologists opportunities to better understand the occurrence, determinants, and severity of PAD. This is particularly relevant not only because limited data suggest differences in the prevalence of PAD among population subgroups but also because it has been suggested that there may be racial differences in the severity of occlusive disease (1) .
Population studies of PAD have been hindered by the variety of definitions of the disease and by the lack of measures that can be administered in a highly standardized way as part of large studies. The conflict between the use of complex measures in clinical care and the need for ease of implementation in epidemiologic studies has led to varying criteria for PAD diagnosis, including intermittent claudication, arterial calcification, absent pulses, segmental blood pressures, and segmental blood flow measurements. As a result of efforts to assess and standardize methods (2) (3) (4) (5) (6) (7) (8) , as well as the growing number of reports from epidemiologic studies (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) , commonality is developing and is leading toward a standardized approach to data collection and analysis. A consensus is emerging that the ankle brachial index (ABI) currently represents the most appropriate measure of PAD for epidemiologic studies, because it is a noninvasive measure, measurement is relatively easy, and it can be standardized for large-scale studies. Although it is not widely used, the toe brachial index has been proposed as an alternative measure of PAD which avoids the difficulty of measuring the ABI in diabetic persons, where there is an increased prevalence of medial calcification that may Peripheral Arterial Disease in American Indians 331 distort or preclude the measurement of ankle blood pressure (2) .
The Strong Heart Study was established by the National Heart, Lung, and Blood Institute in 1988 to estimate morbidity and mortality from cardiovascular diseases and the levels of cardiovascular disease risk factors in geographically diverse groups of American Indians in Arizona, Oklahoma, and North/South Dakota. As part of that study, data were collected for estimation of the prevalence of PAD and associated risk factors. This report provides estimates of the prevalence of PAD and associated risk factors found in a cross-sectional study of three adult American Indian populations. Risk factor levels and severity of disease are compared with well established data on the white population and the limited amount of data available on other minority populations.
MATERIALS AND METHODS
The baseline Strong Heart Study examination was performed in 1989-1992. It was designed to collect uniform epidemiologic data on cardiovascular diseases and risk factors in geographically diverse American Indian communities. Over 1,500 adult men and women aged 45-74 years were examined at each of three centers (total sample = 4,549). The Arizona center included the Pima and Maricopa Indians from the Salt River and Gila River areas and the Pima/Papago (Tohono O'odham) Indians from the Ak Chin community. In Oklahoma, the center covered seven tribes from southwestern Oklahoma, including the Apache, Caddo, Comanche, Delaware, Fort SU1 Apache, Kiowa, and Wichita. In the Dakotas, three tribes of Sioux Indians were examined: the Oglala Sioux and the Cheyenne River Sioux from South Dakota and the Spirit Lake Tribe from North Dakota. All tribal members who met the age criteria and who resided in these communities were invited to participate. Protocols for this study were approved by the local institutional review boards, and all participants provided signed informed consent Response rates were 71.8 percent in Arizona, 61.5 percent in Oklahoma, and 55.3 percent in North/South Dakota, which are comparable to or higher than participation rates for other large epidemiologic studies of cardiovascular disease (Atherosclerosis Risk in Communities-67 percent; Cardiovascular Health Study-57.3 percent) (25, 26) . The lowest response rate, in South Dakota, reflects in part the greater distances between clinics and homes on reservations in that state. In addition, participants were more likely to be female, younger, and nonsmokers. Of the original sample of 4,549 persons, 273 (6.0 percent) were missing an ABI measurement. Thus, 4,276 measurements were available for initial analyses of ABI. Of the 273 subjects missing data on the ABI, 143 had the measurement attempted but their pulse could not be obliterated; 130 had no ABI data available.
Details on the study design and methods (27) , baseline risk factor data (28) , and the prevalence of cardiovascular disease (29) and diabetes mellitus (30) have been presented elsewhere. The methods used to measure variables relevant to this report are briefly reviewed below.
Blood pressure was measured by taking three consecutive measurements of brachial artery pressure in the right arm with the subject in the sitting position, using a Baum mercury sphygmomanometer (W. A. Baum Company, Copiaque, New York). The initial measurement was taken after a 5-minute rest, with 1 minute between successive measurements; diastolic blood pressure was recorded at Korotkoff phase 5. The mean of the last two measurements was used for blood pressure determination and diagnosis of hypertension according to the criteria of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (31) .
Right arm blood pressures and bilateral ankle blood pressure, measured by an Imex Doppler (Imex Medical Systems, Golden, Colorado), were taken separately while the subject lay supine. The right arm, right ankle, and left ankle pressures were taken twice, with both measurements being recorded. The means of the two measurements for each leg and for the arm were used to calculate the ABI, and the lower value of the two ABIs was used to assess PAD. PAD was diagnosed if the ABI was less than the cutoff value. Additional measurements included in the protocol for assessment of PAD were auscultation for femoral bruits and palpation of the posterior tibial and dorsalis pedis pulses by study staff who had been centrally trained and certified.
Obesity was assessed by calculation of the body mass index (weight (kg)/height (m) 2 ) and by measurement of percentage of body fat using an RJL bioelectrical impedance meter (model B1A101; RJL Equipment Company, Detroit, Michigan). An equation validated in a large multiracial data set by the manufacturer was used to estimate percentage of body fat. Waist circumference, measured at the umbilicus with the subject lying in the supine position, and hip girth, measured at the level of maximum protrusion with the subject standing erect, were used to calculate the waist:hip ratio.
Laboratory tests were all performed centrally. Fasting glucose and insulin levels were measured in all subjects and, for those without a history of diabetes, a 2-hour post-75-g-load glucose level was also determined.
Diabetes was defined according to World Health
Am J Epidemiol Vol. 149, No. 4, 1999 Organization criteria using fasting and 2-hour glucose levels or a history of diabetes (27) . Insulin-dependent diabetes mellitus is very rare among American Indians; thus, Indian individuals with diabetes are presumed to have non-insulin-dependent diabetes mellitus. Laboratory tests also included assessment of plasma lipid level, lipoprotein and apolipoprotein levels, fibrinogen level, and urinary albumin and creatinine concentrations, measured by standardized methods (32) . Lipid and lipoprotein levels were measured directly using the standard procedures of the Lipid Research Clinics (33) at the study's central laboratory (Medlantic Research Institute, Washington, DC). Fasting and 2-hour plasma glucose levels were determined by enzymatic methods using a Hitachi chemistry analyzer (Boehringer Mannheim Diagnostics, Indianapolis, Indiana), and fasting insulin level was measured by the method of Morgan and Lazarow (34) at the Medlantic Research Institute. Hemoglobin Ale was measured by high pressure liquid chromatography (35) . Urinary albumin was measured using a nephelometric immunochemical procedure (36) and creatinine was measured using an automated alkaline picrate method (37) at the National Institute of Diabetes and Digestive and Kidney Diseases laboratory in Phoenix, Arizona. The urinary albuminxreatinine ratio was calculated to estimate daily urinary albumin excretion as albumin per gram of creatinine. Albuminuria was defined as microalbuminuria if the albuminrcreatinine ratio was >30 mg/g and <300 mg/g, and as macroalbuminuria if the albuminxreatinine ratio was >300 mg/g. Fibrinogen was measured at the University of Vermont (Burlington, Vermont) by the Dade method, which is based on the clotting time of citrated plasma, using 100 National Institutes of Health units per milliliter of thrombin (38) .
Information on each participant's medical history and lifestyle characteristics, including cigarette smoking and alcohol consumption, percentage of Indian blood (blood quantum), sociodemographic characteristics, and family history was gathered through an interviewer-administered questionnaire. The World Health Organization/Rose questionnaire (39), which includes an assessment of intermittent claudication, was also administered.
The distributions of data on insulin, glucose (fasting and 2-hour), and triglyceride levels were sufficiently skewed to require natural logarithmic transformation for analysis. Analysis of covariance was used to test the significance of the relation of each putative risk factor with PAD, with adjustment for age and center. For variables that were not normally distributed, rank analysis of covariance was used to compute p values. The models were adjusted for age using a continuous variable and for center using indicator variables for the South Dakota and Oklahoma centers. Logistic regression analysis was used to test the significance of the relations of dichotomous risk factors with PAD. Stepwise multiple logistic regression was used to compute prevalence ratios and 95 percent confidence intervals for multivariate analyses. The percentage of the variance explained by the logistic regression model was estimated according to the method of Cox and Snell (40) . All analyses were performed using version 6.10 of the Statistical Analysis System (SAS Institute, Cary, North Carolina).
RESULTS
The distribution of the Strong Heart Study sample by center, gender, and diabetes status is shown in table 1. The sample size (n = 4,304 after exclusion of those with missing data) was almost evenly divided among the three centers, with about 1,500 subjects per center.
Women represented approximately 60 percent of the sample. Non-insulin-dependent diabetes mellitus was highly prevalent at the three centers, with Arizona rates (-69 percent) being about twice the rates of the other two centers. Table 2 shows the frequency of various signs and symptoms of PAD by center and gender. Three ABI thresholds for the definition of PAD-<0.8, <0.9, and <0.95-are presented, for comparison with the variety of definitions used in other studies (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) . These crite- ria provided prevalence estimates of approximately 2 percent, 5 percent, and 6-11 percent, respectively, across centers. For all centers combined, the prevalence of an ABI less than 0.9 (the most frequently used threshold in the literature) was 5.3 percent for the total sample (4.8 percent for men and 5.6 percent for women). Prevalence estimates were consistently higher for women than for men across centers. Data on other measures of PAD shown in table 2 include absent pulses, femoral bruits, intermittent claudication (by Rose questionnaire), and lower limb amputation. The prevalences of absent posterior tibial pulses were quite variable among centers, but women had consistently higher rates than men at all centers. At the Arizona center, approximately 51 percent of women and 44 percent of men had absent posterior tibial pulses by palpation. The prevalence of absent dorsalis pedis pulses varied from 1.6 percent to 8.3 percent, with higher rates being seen in men than in women at the Arizona and Oklahoma centers. The absence of both dorsalis pedis pulses and posterior tibial pulses was also higher at the Arizona center than at the other two centers. Intermittent claudication by Rose questionnaire was prevalent in less than 1 percent of men and women across all centers. Nontraumatic amputation of a lower limb was considerably more prevalent at the Arizona center than in Oklahoma and South Dakota for both men and women. Table 3 shows the distributions of alternative measures of PAD according to whether or not the ABI was less than 0.90. This table provides an assessment of the overlap between conditions associated with PAD and the endpoint (ABI <0.9) used for the remainder of this paper. Every measure of PAD was significantly more prevalent in the group with ABI <0.9 than in those with ABI >0.9. Prevalence ratios ranged from 1.9 to 6.5. Table 4 summarizes the results of univariate analyses for men and women, comparing mean values for continuous risk factors in persons with and without PAD (ABI <0.9), adjusted for age and center. Initial models for stepwise multiple logistic regression analyses included all variables that were related to PAD in tables 4 and 5 or frequently cited in the literature. Table 6 shows the final model resulting from the stepdown procedure, for men and women combined. In the final model from stepwise multiple logistic regression analysis, age, current cigarette smoking, pack-years of smoking, systolic blood pressure, albuminuria (micro-and macro-), fibrinogen, and low density lipoprotein cholesterol were positively associated with PAD and current alcohol consumption was negatively associated with PAD. Gender did not contribute significantly to this model, which is consistent with the similarity of univariate correlates of PAD in women and men. A test for interactions between gender and other variables also did not produce significant results.
The above analyses identified PAD by the well standardized endpoint of ABI <0.9 and ignored other indications of PAD. Multiple logistic regression analyses were rerun after eliminating the "potential events" (excluding from the noncases those with absence of both pulses, femoral bruits, intermittent claudication, and amputation) in the subjects with ABI ^0.9. Observations for 164 subjects were eliminated from the group without disease, but the final model included the same significant variables, with slightly stronger odds ratios for microalbuminuria (1.81 vs. 1.79) and macroalbuminuria (2.75 vs. 2.54) and equal or higher bounds for the 95 percent confidence intervals. PAD among three diverse populations of American Indians helped to answer four questions: 1) Do rates of PAD differ among subgroups of American Indians? 2) Are rates of PAD in American Indians different from those in other populations based on standard data collection? 3) What risk factors are associated with prevalent PAD in American Indians? 4) Is there any indication that the severity of PAD differs among subgroups of American Indians?
These cross-sectional data indicate that there is little evidence of center differences in PAD among these three geographically diverse groups of American Indians. The overall prevalence of PAD as defined by ABI <0.9 was 4.8 percent in men and 5.6 percent in women in the 45-to 74-year-old age group.
The prevalences of PAD in Strong Heart Study participants appear consistent with those in other studies (table 7) , after taking into account differences in the definition of PAD and the age/gender distributions of the comparison study samples. Ten of the 14 studies listed in table 7 provided data using a 0.9 threshold value of ABI for their definition of PAD. Five of these studies (7, 8, 10, 14) included persons in age ranges beneath the age range of the Strong Heart Study; and all of the studies-with the exception of the study by Hiatt et al. (7), who found a rate of 7.1 percent in the San Luis Valley Diabetes Study-found prevalences in the range of 2.0-5.4 percent. Among the five studies with age ranges above that of the present study (11, (14) (15) (16) (17) (18) (19) , all reported higher prevalences, although some included samples of persons with known morbid conditions related to PAD (15, 18) . The amount of data on PAD in nonwhites is limited. The Cardiovascular Health Study reported higher rates of PAD among nonwhite (predominantly black) participants (7) . The Atherosclerosis Risk in Communities Study found prevalences of PAD (ABI <0.9) among adults aged 45-64 years of 3.9 percent for black women, 2.7 percent for white women, 3.1 percent for black men, and 2.0 percent for white men (41) .
This study also confirmed that the prevalence of PAD among American Indians is associated with many of the same risk factors as seen in other populations. The significant positive relations of PAD with age, current cigarette smoking, and systolic blood pressure confirm findings from other studies. Pack-years of cigarette smoking were also significantly related to ABI <0.9 in this study. A new finding from this study is that albuminuria, as a measure of renal dysfunction, is positively related to PAD and appears to equal or exceed cigarette smoking as a correlate of PAD among American Indians. Fibrinogen level was also shown to be significantly related to PAD. Similar results on fibrinogen were found in the Cardiovascular Health Study, the Atherosclerosis Risk in Communities Study, and the Edinburgh Artery Study, the only other studies that included a measure of fibrinogen (17, 19, 41, 42) . Lowe et al. (42) found a significant association of pack-years of cigarette smoking with PAD in women but not in men, and a stronger relation of fibrinogen with PAD in men than in women. They also found a stronger relation of fibrinogen with ABI as lifetime smoking increased.
Although univariate analyses indicated that diabetes, duration of diabetes, and sequelae of diabetes were significantly and consistently related to PAD for both men and women, in this population, indicators of renal dysfunction (albuminuria) and inflammation (fibrinogen) appeared to be most strongly related to PAD in multivariate analyses. This suggests that microalbuminuria is both a direct measure of renal microvascular disease and an indirect measure of more generalized macrovascular disease. If albuminuria is excluded from the multivariate analysis, duration of diabetes enters in its place. Among participants with macroalbuminuria, 90 percent also had diabetes; among those with microalbuminuria, 76 percent had diabetes. The prevalence ratios indicate that albuminuria is associated with a risk of PAD equal to or exceeding that of cigarette smoking. In populations with a high prevalence of diabetes, it would appear that assessments of albuminuria and fibrinogen levels should be included in any study of PAD.
Interestingly, alcohol consumption was negatively related to PAD. The relation of alcohol to PAD tended to be strengthened when high density lipoprotein cholesterol was dropped from the stepwise logistic regression models and may, in part, reflect the same underlying association. A negative relation of high density lipoprotein cholesterol to PAD has been shown previously (15, 43) . An inverse relation of PAD to alcohol consumption was found by Gofin et al. (14) , but only in women. A negative relation between PAD and alcohol consumption was suggested in the Edinburgh Artery Study (42) , although the relation did not remain significant in the multivariate analyses. The alcohol association in this study may also reflect the crosssectional nature of these data.
Although the rates of PAD as defined by ABI <0.9 were similar at the three study centers, by a more broadly defined measure of PAD-one which incorporates microvascular disease as well as other measures of macrovascular disease-rates differed significantly among centers, with the Arizona center demonstrating substantially more disease. The prevalences of amputation were quite variable, with rates for Arizona Indians being significantly higher than those of Indians at the other two centers. The higher rates among Arizona Indians may be related to the higher prevalence of diabetes in this group or to other metabolic or genetic factors. A high proportion of amputations (140/153 = 91.5 percent) was identified among the diabetic participants. The prevalences of femoral bruits and intermittent claudication were fairly constant among centers and between genders. The 2 percent prevalence of bruits was less than the 6 percent found in an older population by Criqui et al. (44) .
Rates of intermittent claudication as assessed by the Rose questionnaire were similar to those reported in the literature, although most studies of intermittent claudication are studies of older populations. In the Whitehall Study (23) , rates of 0.8 percent for probable intermittent claudication and 1 percent for possible intermittent claudication were found among 18,388 subjects aged 40-64 years. In the Systolic Hypertension in the Elderly Project (15), 6.4 percent of hypertensive men and women aged 60 years and older had intermittent claudication. De Backer et al. (8) found rates of <1 percent in subjects aged 18-55 years from Belgium and the Netherlands. Schroll and Munck (11) reported rates of 5.8 percent for men and 3.1 percent for women aged 60 and over in Denmark. Criqui et al. (12) found rates of 2.2 percent in men and 1.7 percent in women among persons with an average age of 66 years. As was noted in a recent international workshop (2), intermittent claudication assessed by Rose questionnaire is suspect in that it is prone to false negative findings and lacks data on laterality.
The absence of posterior tibial pulses in almost 50 percent of the women and men in Arizona is perplexing. Review of the procedures and spot checking by a second technician confirmed that examinations followed the standardized protocol. It appears that palpation of pulses in Arizona Indians as a group is difficult. The rate of amputation was fivefold higher among the Arizona Indians, and the frequency of absent dorsalis pedis pulses was also higher. Among those with ABI <0.9, 33.5 percent also had absent posterior tibial pulses versus 17.2 percent among those with ABI >0.9. While the Arizona center appears to have had higher rates of PAD as measured by other signs and symptoms, the absence of palpable posterior tibial pulses among Arizona Indians being 5-to 20-fold more frequent than at the other centers may be the result of severe obesity or edema, and thus not a valid measure of PAD. Another possibility is that absent pulses are the result of anatomic differences among populations; such differences have been described for the absence of dosalis pedis pulses (12, 21) . The difficulty of palpating pulses has long been noted, and recent recommendations suggest that absent pulses be confirmed by a second trained observer and that absent pulses not be used alone as primary endpoints in epidemiologic studies (2) .
Equally perplexing is the finding that, while the Arizona Indians have significantly higher rates of diabetes and sequelae of diabetes, such as absent pedal pulses and amputations, they have significantly lower rates of prevalent coronary heart disease (29) . Further study is needed to determine why the Arizona Indians experience more complications of PAD than other tribal groups. However, it is clear that in all tribes it is important to screen diabetic patients for sequelae of diabetes and to implement preventive measures among them as early as possible.
What is not clear from this study, because of its cross-sectional design, is the sequence of events and whether any of these associations reflect cause and effect. Answers to such questions must await longitudinal data collection, which is currently ongoing in this minority population.
In conclusion, the prevalences of PAD among American Indians included in this study do not appear to differ from those seen in other populations. Factors associated with the risk of PAD are also similar to those that have been found in other populations. Albuminuria appears to be an additional factor associated with PAD in American Indians, and to be at least as strongly associated with PAD as cigarette smoking.
